Financhill
Back

Madrigal Pharmaceuticals Quote, Financials, Valuation and Earnings

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Buy
68

MDGL
Madrigal Pharmaceuticals

Last Price:
338.08
Seasonality Move:
34.75%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Madrigal Pharmaceuticals Price Quote

$338.08
+0.47 (+0.14%)
(Updated: November 6, 2024 at 5:55 PM ET)

Madrigal Pharmaceuticals Key Stats

Buy
68
Madrigal Pharmaceuticals (MDGL) is a Buy

Day range:
$316.67 - $337.63
52-week range:
$133.99 - $337.63
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
9.47%

Volume:
771.3K
Avg. volume:
459.9K
1-year change:
129.84%
Market cap:
$7.4B
Revenue:
$0
EPS:
$-25.12

How Much Does Madrigal Pharmaceuticals Make?

Data Unavailable

Is Madrigal Pharmaceuticals Growing As A Company?

Data Unavailable

Madrigal Pharmaceuticals Stock Price Performance

What Is Madrigal Pharmaceuticals 52-Week High & Low?

Madrigal Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Madrigal Pharmaceuticals?

Is Madrigal Pharmaceuticals Cash Flow Positive?

  • What Is MDGL Cash Flow From Operations?
    Cash flow from operations (TTM) is -$431M
  • What Is Madrigal Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.2B
  • What Is Madrigal Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$588.6M

Madrigal Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    MDGL return on invested capital is -74.25%
  • What Is Madrigal Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -62.74%
  • What Is MDGL Return On Equity?
    ROE is a measure of profitability and is -89.04%

Madrigal Pharmaceuticals Earnings Date & Stock Price

Madrigal Pharmaceuticals Competitors

Madrigal Pharmaceuticals Dividend Yield

Madrigal Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 28.8%
Revenue: 0% 80.67%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 368.87
Upside from Last Price: 9.26%

Major Shareholders

  • How many MDGL shares are owned by institutional investors?
    36.1M MDGL shares are owned by institutional investors
  • How many MDGL shares are owned by insiders?
    9M MDGL shares are owned by insiders